DLK1 and hepatoblastoma: Through spatial transcriptomics analyses of multiple hepatoblastoma-like malignancy samples, Fang J. et al. [23] found that the expression of Dlk1, Epcam, and Gpc3, the embryonal hepatoblastoma stem cell markers, exhibited intertumoral heterogeneity, and the differentiation degree of tumors varied among different patients.